Steris (STE) Receivables - Other (2019 - 2020)

Steris (STE) recorded quarterly Receivables - Other of $9.0 million in Q4 2020, up 4.93% quarter-over-quarter from $8.5 million in Q3 2020.

Steris (STE) Receivables - Other (2019 - 2020) Analysis & Trends

Steris' Receivables - Other history runs 2 years deep, the most recent figure standing at $9.0 million for Q4 2020.

In Q4 2020, Receivables - Other changed N/A year-over-year to $9.0 million; the TTM figure through Dec 2020 stood at $9.0 million (changed N/A YoY), while the FY2020 annual figure was $8.1 million, down 4.97% from the prior year.
Receivables - Other was $9.0 million for Q4 2020 at Steris, up from $8.5 million in the prior quarter.
In the past five years, Receivables - Other ranged from a high of $9.0 million in Q4 2020 to a low of $8.1 million in Q1 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn
10	Zimmer Biomet Holdings	17.18 Bn	16.77 Bn	1.51 Bn

Download Data